Saturday, 23 February 2019

Dosimeters Market Expansion to be Persistent During 2018–2026


Dosimeters devices are used for radiation detection or monitoring. The dosimeters are majorly used in the hospitals, ambulatory care centers, research institute, and healthcare companies for measuring radiation exposures of individuals working under radiation. Dosimeters are categories in two productive type active dosimeters and passive dosimeters. Active dosimeters measure the radiation and provide instant results with LED screens, alarm, or vibrations. Passive dosimeters record the radiation exposure but the readings are measured in laboratories, they do not give instant results.


Increasing adoption of radiation emitting diagnostic tools and therapies is expected to propel demand for dosimeters

Increasing adoption of radiation emitting diagnosis tools such as CT scans and MRI by hospitals, ambulatory care centers, and others is expected to increase the demand for dosimeters among healthcare professionals operating these tools, which in turn is driving the global dosimeters market growth. For instance, according to the data published by the Organization for Economic Co-operation and Development (OECD), in the U.S., the total unit of Magnetic Resonance Imaging (MRI) in hospital and ambulatory care centers in 2015, were around 39.0 per 1,000,000 inhabitants, which increased from 31.5 per 1,000,000 population in 2010. Furthermore, recent past has witnessed high adoption of nuclear medicines and radiotherapy for diagnosis of different types of disease such as cancer and some neurological disorders. Hence, increasing prevalence of cancer is expected to increase demand for radiotherapy and nuclear medicines, which in turn is expected to increase demand for dosimeters for healthcare professional working with these radiation emitting substances. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

The global dosimeters market size was US$ 847.0 Mn in 2017, and is expected to witness a CAGR of 4.2% over the forecast period (2018 – 2026).

Frequent launches of novel dosimeters by key players is expected to drive dosimeters market growth

Key players are engaged in launching novel dosimeters in the market, which is expected to drive the global dosimeters market growth. For instance, in April 2018, Tracerco, part of the FTSE100 company, Johnson Matthey Plc. launched two Personal Electronic Dosimeters (PEDs) – the PED-ER and PED-ER+. In 2013, Polimaster Ltd., launched a new Radiation Detector POLISMART II PM1904. This new dosimeter work as a non-wearable gadget, which is connected to iPhone via dock-port and radiation is measured with the help of application in phone.

Key players in the market are engaged in strategic mergers and collaborations for the development of novel dosimeters. For instance, in 2012, Royal Philips Electronics collaborated with Unfors RaySafe, Inc. for the development of next-generation Philips DoseAware system, which is used to measure an individual’s exposure to radiation in real-time. In 2017, PTW Freiburg GmbH and Elekta Pty Ltd (Elekta South Africa) entered into a strategic partnership to promote dosimetry education in South Africa. According to the partnership, PTW Freiburg GmbH trained Elekta’s customers and provided basic and advanced dosimetry education through its learning platform, the PTW Dosimetry School.

Key players operating in the dosimeters market include Thermo Fisher Scientific Inc., PRS Dosimetry, Mirion Technologies Inc., Landauer Inc., Polimaster Ltd., Radiation Detection Company Inc., Sierra Radiation Dosimetry Services Inc., Tracerco Limited, Unfors RaySafe AB, and PTW Frieburg GmbH.


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Test Phantom Market Outline New Developments with Operational Updates


Test phantoms or imaging phantoms are specially developed objects used in the field of medical imaging for testing, evaluation, and calibration of various imaging devices. Medical test phantoms are artificial tissue-equivalent materials used as replacement for human tissues to ensure that methods and systems used for imaging human body are working appropriately.

A test phantom is readily available and offers more reliable results than the use of human volunteers. Various test phantoms are available in the market such as CT test phantom, mammography test phantom, ultrasound test phantom, radiation oncology test phantom, and MRI test phantoms. Each type of the test phantom offers diverse information about the body part being examined for injury or disease treatment. Recent advances in test phantom techniques provide a better non-invasive solution for identifying various chronic diseases and treatment associated with it.


Test Phantom Market – Dynamics

Increasing prevalence of various chronic diseases such as HIV, tuberculosis, and cancer is expected to contribute to significant growth of the test phantom market. For instance, according to the World Health Organization key fact 2018, cancer was the second leading cause of death worldwide and was responsible for 8.8 million deaths in 2015. Moreover, medical imaging is one of the important parts of healthcare industry, as nearly all the diagnostics and treatment are based upon the analysis provided by the imaging techniques.

Increasing use of imaging techniques in the healthcare sector is expected to propel growth of the test phantom market. For instance, according to National Health Services (U.K.) diagnostic imaging dataset statistical release, around 41 million medical imaging tests were reported in England in 2017, 3.49 million imaging tests were recorded in January 2017, with radiograph being performed 1.89 million times, followed by diagnostic ultrasonography (Ultrasound, 0.77 million), computerized axial tomography (CT scan, 0.40 million), and magnetic resonance imaging (MRI, 0.28 million). Furthermore, government funding for enhanced imaging solutions is expected to significantly boost the market growth. For instance, in 2014, the U.K Government funded US$ 27,327,000 to build an Imaging Center for Excellence (ICE) at the University of Glasgow. However, high maintenance cost related with medical test phantoms is expected to hamper the market growth.

Test Phantom Market – Regional Insights

Based on the region, the global test phantom market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America held dominant position in the global test phantom market during forecast period. This is owing to increasing research and development activities in imaging technologies in the region. Moreover, increasing use of diagnostic services by healthcare facilities is expected to propel growth of the market. For instance, according to National Science and Technology Council 2017 report, 79 million CT scans, 39 million MRI scans, and 1.7 million PET scans were performed in the U.S in 2015.

Test Phantom Market – Competitive Landscape

Major players operating in the test phantom markets include,

1. Fluke Corporation
2. IBA
3. Sun Nuclear Corporation
4. Biodex Medical Systems
5. Standard Imaging
6. Capintec
7. Pro-Project
8. The Phantom Laboratory
9. RaySafe
10. Carville
11. CIRS
12. Kyoto Kagaku Co., Ltd
13. Modus Medical Devices
14. Radiology Support Devices
15. 3-Dmed

Key players are focused on adopting market strategies such as collaboration, mergers, and new product launch in order to retain dominant position in the market. For instance, in 2014, Kyoto Kagaku Co., Ltd launched Female Pelvis Ultrasound Phantom US-14a and US-14b, it has features such as accurate cerebral anatomy just like human brain.

Else place an Enquiry Before Purchase " Test Phantom Market Size, Share, Outlook, Forecast 2026" Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2287

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Friday, 22 February 2019

Alzheimer’s Drugs Market Report 2025: Includes Latest Key Development and Market Dynamics


The Alzheimer’s disease is one of the most prevalent neurodegenerative disease, which is associated proportionately with increased life expectancy worldwide. Patient suffers and encounters various behavioral change with dementia, as a primary symptoms, which gets worse as disease progress. It majorly affects people of age group 65 and above. Currently, there is no therapeutic cure available for Alzheimer’s disease, however, available drugs can lower symptoms or severity of the disease. Although many companies have invested in the development of new drug for Alzheimer’s disease, a very few molecules have shown a steady improvement in condition of patient and many of those investigational candidates failed to provide significant improvement in patients condition during phase three clinical trials.


Market Dynamics

Major factor fueling growth of the Alzheimer’s drugs market is large number of drugs in pipeline, which are expected to enter into market by 2022. According to the study published by Translational Research and Clinical Intervention in September 2017, there are 105 new drugs in pipeline, out of which 25 are in phase one, 52 in phase two and 28 are in phase three. These new products has novel approach such as immunotherapy to target amyloid beta, beta-site amyloid precursor protein cleaving enzyme 1 inhibitors, tau aggregation inhibitor, serotonin 5-HT6 receptor antagonist. Along with this there is an increase amount of collaboration amongst companies for developing drugs in joint effort, for instance in November 2017, Novartis and Amgen, along with the Banner Alzheimer's Institute, announced a collaboration to assess potential of the BACE1 inhibitor CNP520 to prevent or delay symptoms of Alzheimer's disease. In 2016, AstraZeneca and Eli Lilly and Company entered into worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42 (Aβ42), which is currently in Phase I trials, as a potential disease-modifying treatment for Alzheimer’s disease. These collaborations are expected to accelerate the development process and bring efficiency in entire arena of operations. However, failing of investigational candidate in late stage is expected to be a huge setback in the current Alzheimer’s drugs market, for instance in February 2017, an external data monitoring committee warned that Merck & Co. terminated study of Alzheimer's candidate verubecestat due to potential failure in a Phase II/III study.

Increasing prevalence of Alzheimer’s disease to drive growth of the Alzheimer’s drugs market worldwide

Increasing prevalence and incidence of Alzheimer’s disease worldwide is expected to drive the growth of Alzheimer’s disease therapeutics market. According to World Alzheimer Report in 2016, an estimated 46.5 million people were suffering from Alzheimer’s disease and the number is projected to reach 50 million by 2017, every three second there is new patient of Alzheimer’s disease worldwide.

Increasing age and aging global population are major risk factors for Alzheimer’s, which increase the disease incidence and provide growth opportunity for Alzheimer’s treatment market. For instance, according to World Population Prospects (WPP) published by United Nations in 2017, an estimated 962 million people are of age 60 or above, which accounted for 13 per cent of the global population. The number is projected to reach 1.4 billion by 2030, growing with annual rate of 3 percent.

Key Players - Alzheimer’s Drugs Market

Key players operating in Alzheimer’s drugs market include Pfizer, Inc., Janssen Pharmaceutical, Novartis International AG, Eisai Co. Ltd., Lundbeck A/S and Teva Pharmaceuticals Industries Ltd., Other prominent players whose products are under clinical trials are Eli Lilly and Company, TauRx Pharmaceuticals Ltd, VTV Therapeutics, Hoffman-La Roche Ltd., AstraZeneca plc, and AC Immune.

Detailed Segmentation:

Global Alzheimer’s Drugs Market, By Drugs:
• Donepezil
• Rivastigmine
• Galantamine
• Memantine

Global Alzheimer’s Drugs Market, By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• e-Commerce


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Medical Aesthetics Market Prophesied to Grow at a Faster Pace by 2026


Medical aesthetics is an area of medicine, dealing with aesthetics, well-being, external appearance, visible skin changes, and image of the patient. Medical aesthetics involve high-technology skin care procedures that represents the fusion of beauty and healthcare services. Procedures for these involves use of advanced technologies to enhance aesthetics of the person. Demand for anti-aging products and procedures is increasing significantly, owing to increasing focus of patients to look young and improve their appearance, especially by people aged 50 years and above.


Medical Aesthetics Market: Market Dynamics

Increasing surgical procedures for enhancing personal appearance is a major driver for the global medical aesthetics market growth. For instance, according to International Society of Aesthetic Plastic Surgery (ISAPS), in 2015, women had over 18 million non-surgical and surgical procedures performed, that is around 85.6% of the total aesthetic procedures performed worldwide. The top five surgical procedures performed on women in 2015 were: breast augmentation, liposuction, eyelid surgery, abdominoplasty, and rhinoplasty. Furthermore, men had over 3 million non-surgical and surgical procedures, comprising around 14.4% of the total. The top five surgical procedures performed on men were: eyelid surgery, liposuction, gynecomastia surgery, rhinoplasty, fat grafting, and ear surgery. Male patients are increasingly focusing on undergoing aesthetic procedures, owing to better results with reduced downtime and discomfort. According to another ISAPS report, Botulinum Toxin continues to be the most common form of procedure, women and men undergo. A total number of over 4.6 million procedures are conducted on both the sexes of Botulinum Toxin. Procedures of Hyaluronic acid increased 6.5% from 2014 to 2015, whereas breast augmentation continues to be the most common surgical procedure among women with a 10.4% rise from 2014 and eyelid surgery is prevalent among men.

Medical Aesthetics Market: Regional Insights

Regional segmentation of medical aesthetics market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America medical aesthetics market is expected to hold a dominant position, due to increasing aesthetic procedures in the region. According to American Society for Aesthetic Plastic Surgery, the number of medical aesthetics procedures performed in the U.S. has significantly increased. In 2016, people in the U.S. invested over US$ 15 billion on combined non-surgical and surgical procedures, with non-surgical accounting for 44% of all the procedures.

Medical Aesthetics Market: Competitive Analysis

Major players operating in the medical aesthetics market include Cynosure, Inc., Allergan, Inc., Alma Lasers, Ltd., Mentor Worldwide LLC, Lumenis Ltd., ZELTIQ Aesthetics, Inc., PhotoMedex, Inc., Galderma S.A., Syneron Medical, Ltd., and Solta Medical, Inc. The industry is fragmented and highly competitive in nature with many local players competing with international players.

Medical Aesthetics Market: Market Taxonomy

On the basis of products, the medical aesthetics market is segmented into:

• Breast Implants
• Facial Aesthetics
• Laser Hair Removal Devices
• Physician-Dispensed Cosmeceuticals and Skin Lighteners
• Tattoo Removal Devices
• Physician-Dispensed Eyelash Products
• Laser Resurfacing Devices
• Thread Lift Products
• Fat Reduction Devices

On the basis of end user, the medical aesthetics market is segmented into:

• Beauty Centers
• Clinics and Medical Spas


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Respiratory Syncytial Virus Diagnostics Market is set to experience revolutionary growth by 2026


Respiratory Syncytial Virus (RSV) is responsible for many chronic conditions such as pneumonia, bronchitis, asthma, and respiratory disease. It primarily affects neonates, infants and adults and is responsible for outpatient visits, hospitalization and death in some cases. Therefore, diagnosis of RSV- associated diseases is crucial to avoid further medical severity. Symptoms of RSV presence include, rhinorrhea, cough, wheeze, respiratory distress, and hypoxemia. Molecular diagnostic is most widely used techniques for diagnosing RSV.

Respiratory Syncytial Virus Diagnostics Market - Market Dynamics

High prevalence of respiratory infections due to RSV is a major factor driving growth of the respiratory syncytial virus diagnostics market. According to a report by the Lancet, 2017, around 33·1 million episodes of RSV induced acute lower respiratory infections that resulted in around 3·2 million hospitalizations and around 59,600 in-hospital deaths in children younger than 5 years of age, worldwide, in 2015. Moreover, the report stated that the overall RSV- acute lower respiratory infections- related mortality was around 118200 in 2015.

Ask for In-depth Sample Copy of This Research at https://www.coherentmarketinsights.com/insight/request-sample/2038

Furthermore, high prevalence of several chronic conditions such as pneumonia and other respiratory tract infections due to RSV is a major factor contributing to growth of the market over the forecast period. For instance, according to a report by World Health Organization (WHO), May 2018, chronic obstructive pulmonary disease (COPD) and lower respiratory tract infection are amongst top five chronic diseases with highest mortality rate, worldwide. The report stated that around 3 million each deaths were registered due to COPD and lower respiratory tract infection in 2016, worldwide.

Respiratory Syncytial Virus Diagnostics Market - Regional Insights

On the basis of Geography, respiratory syncytial virus diagnostics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be dominant in the respiratory syncytial virus diagnostics market over the forecast period. According to study published in journal American Family Physician in 2017, around 2% to 3% of infants, younger than 12 months are hospitalized with an RSV infection, annually, in the U.S. As per same source, Around 57,500 hospitalizations and 2.1 million outpatient visits are associated with RSV infections in children younger than five years, annually, in the U.S. It can be concluded from epidemiological data that the U.S. has high potential for respiratory syncytial virus diagnostics market. Presence of key players and their products in North America would be another important driver for the market growth.

Respiratory Syncytial Virus Diagnostics Market - Competitive Landscape

Key players operating in the respiratory syncytial virus diagnostics market include, F. Hoffmann La-Roche AG , Becton, Dickinson and Company, Novartis AG, Abbott Laboratories, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., BioMerieux, DiaSorin SPA, Millipore-sigma, Quidel Corporation, Alere Inc., Coris BioConcept, Fast-track Diagnostics, and Quest Diagnostics.

Respiratory Syncytial Virus Diagnostics Market - Market Taxonomy

- On the basis of diagnostic techniques: Molecular Diagnostics, Direct Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test, Monoclonal Antibodies, Flow Cytometry, Diagnostic Imaging, Immnunochromgraphic Assay, Gel Microdroplets, Others
- On the basis of end user: Hospitals, Diagnostic Centers, Commercial Radioisotope Manufacturers
- On the basis of region: North America, Latin America, Europe, Asia Pacific, Middle East, Africa


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Adaptive Strollers Market: Up-to-Date Analysis of Latest Trends in Market 2026


Adaptive stroller is a special mobility equipment that is designed to offer smooth mobility and comfortable seating for patients with neurodegenerative disorders. It offers a lighter and more portable alternative to wheelchair. Adaptive strollers can be equipped with accessories that help with comfortable positioning and posture. For younger children, strollers are an appropriate alternative to a wheelchair and are more easily transported in cars than heavier wheelchairs. Adaptive strollers are available for nearly all sized clients and frame adjustments and seating options vary significantly among different models.

The global adaptive stroller market size was valued at US$ 313.4 million in 2017 and is expected to witness a CAGR of 7.8% over the forecast period (2018 – 2026).


Increasing prevalence of neurodegenerative diseases is expected to drive the adaptive stroller market revenue

Neurodegenerative disease is an array of conditions, which primarily affects the neurons in the human brain. It is an incurable and devastating conditions that results in progressive degeneration and death of nerve cells, which causes problems with movement or mental functioning. Spinal Muscular Atrophy (SMA) and motor neuron diseases are the most common neurodegenerative diseases in children. SMA affects the motor neurons that control body movement. According to a report published in the PLOS One journal, 2018, SMA is the leading genetic cause of infant death worldwide, with an incidence of around 1 per 10,000 newborns worldwide. Cerebral palsy is also the most common motor disability in childhood. According to the Centers for Disease Control and Prevention’s (CDC) 2014 report, an average of one in every 323 children in the U.S. suffer from cerebral palsy.

Adaptive Strollers Market - Regional Insights

On the basis of region, the global adaptive strollers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America adaptive strollers market is expected to generate major revenue share during the forecast period. This is owing to increasing investment of government in the healthcare sector coupled with a large number of children suffering from mobility disorders. According to the CDC 2014 report, the expenditure on treatment for a child with Autism Spectrum Disorder (ASD) was US$ 17,000, annually and it increased to over US$ 21,000, annually for a child with more severe ASD.

Europe adaptive stroller market size is expected to witness significant growth, owing to higher prevalence of SMA in the region and increasing charity and funding for adaptive stroller by various government and private organizations such as The ACT Foundation, Action For Kids, and Cerebra. According to the NHS 2014 report, approximately 5,500 to 6,000 people in the UK were suffering with some form of SMA.

Adaptive Strollers Market - Competitive Landscape

Key players operating in the global adaptive strollers market include,

1. Adaptive Star
2. Assistive Technology, Inc.
3. Convaid Products, Inc.
4. Deming Designs Inc.
5. Eurovema Ab
6. Invacare Corporation
7. Meyra
8. Ormesa
9. Performance Health
10. Special Tomato
11. Sunrise Medical LLC
12. R82 Inc.
13. Thomashilfen.us

Else Place and Enquiry Before Purchase This Business Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2253

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Thursday, 21 February 2019

Surgical Tourniquets Market Prognosticated For A Ravishing Growth By 2026


Surgical tourniquets are majorly used in plastic surgeries and orthopedic surgeries. Surgical tourniquets prevent blood flow to a particular limb, enabling surgeons to work efficiently without the flow of blood in that particular limb which needs to be operated. Surgical Tourniquet devices help surgeon to improve precision and speed with all safety measures. It is majorly used by military surgeons to stop the flow of blood and also for cannulation. Disposable cuffs are frequently used devices to stop the flow of blood as there is negligible risk of cross contamination as these devices are discarded immediately after their use.
A tourniquet is a compressing or constricting device used to control arterial and venous circulation for a long period of time. Major amount of blood is lost in situations such as open surgeries performed on patients with serious affliction or accidents.

Download PDF Brochure of This Business Report at https://www.coherentmarketinsights.com/insight/request-pdf/1736

Surgical Tourniquets Market Key Players:-

Key players operating in surgical tourniquets market include Anetic Aid, Zimmer Biomet, Stryker Corporation, Hammarplast Medical AB, Delfi Medical Innovation, Ulrich Medical, Riester, Hangzhou Keyu, Medic Instrument, Bohua Medical, Pyng Medical Corporation and Others. A.T.S 4000 Tourniquet System is a new surgical tourniquet device from Zimmer Biomet. It has the following features Personalized Pressure technology, Limb Occlusion Pressure, Dual Port, Dual Cuff, Table or Mole Point, Lithium Ion Battery-6 hours, Touch screen User Interface, and advanced Leak Detection.

Surgical Tourniquets Market Drivers:-

Rapid technology advancement in disposable tourniquet cuff is expected to be a major driver for growth of the surgical tourniquets market. According to a study conducted by the U.S. National Library of Medicine-National Institutes of Health, in 2012, use of tourniquet is associated with certain challenges. For instance, obstructing blood flow to a particular limb may result in ischemia, continuous use of tourniquets may result in permanent nerve injury, skin necrosis, etc. Reperfusion injury is also caused by continuous use of tourniquets, reperfusion of tissues can cause inflammation in the damaged areas further causing their damage, and reperfusion can also affect vital organs. To overcome such problems related to inappropriate use of tourniquets, in 2015, SAM Medical, the US-based company launched new product called SAM XT Extremity Tourniquet. This device uses TRUFORCE Buckle Technology which auto locks at a predetermined force, this prevents all slacks which previously was considered as a hindrance. This is successfully achieved by force control at the baseline, which activates its locking prongs into a strap. Other features of this device are that it requires few windlass turns as compared to the other tourniquet, this enables the product to function faster and can be used easily and lastly it also meets MIL-STD 810G for enduring durability.

Road Accidents are one the major factor leading to death. According to European Commission, in 2014, more than 30,000 people died in Europe due to road accidents. These accidents results into serious damage to spinal cord or brain and also fatal limb injuries. According to a report by India Brand Equity Foundation (IBEF) in 2015, healthcare is the fastest growing sector in India. Increasing cases of limb amputation or limb hemorrhage and orthopedic surgeries in geriatric population are expected to propel demand for surgical tourniquets. According to a study conducted by American Stroke Association, in 2017, Hemorrhagic stroke accounted for 13% of the stroke cases. Limb hemorrhage is a common injury caused during military wars.

Surgical Tourniquets Market Regional Analysis:-

Surgical tourniquets market in Asia Pacific region is projected to witness significant growth over the forecast period, owing to increasing number of geriatric population, as geriatric population is prone to limb amputation, arteriosclerotic vascular disease, and cardiovascular diseases. Commonly used tourniquet for geriatric population are arterial tourniquet. According to a study conducted by Global Burden of Diseases, in 2014, India has more than 32 million heart patients and more than 0.25 million patients are being operated annually. Furthermore, North America region is expected to grow at steady rate due to mergers and acquisitions. For instance, Bound Tree Medical collaborated with SAM Medical as distributors of their latest devise SAM XT Extremity Tourniquet. Another factor that can boost the surgical tourniquet market is use of tourniquets in military. According to a report by North America Rescue, in 2015, The Combat Application Tourniquet is mostly being used by British and the U.S military, it is effective, small and portable, which can be easily used by militants. It is also used by National Health Service (NHS) Ambulance. According to International Labor Organization (ILO), in 2014, around 3739 cases of fatal industrial accidents were reported in EU, which in turn is fueling growth of the surgical tourniquet market in Europe.


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Pressure Monitoring Devices Market Sales And Product Demand Analysis 2026


Hypertension, also called as High Blood Pressure (HBD) is the major cause of concern among . It is a long term medical condition, which affects blood pressure in the arteries. The long term high blood pressure may result , major health complications such as stroke, heart failure, coronary artery disease, atrial fibrillation, vision loss, and other problems. According to the American Heart Association, Inc. report in 2013, around 77.9 million (1 out of every 3) adults are suffering from high blood pressure in the U.S. Pressure monitoring devices effectively monitor and measure various types of pressure such as blood pressure, pulmonary pressure, and intraocular pressure. Pressure monitoring devices are available in various types and sizes depending on the requirement of the application. Increasing adoption of is due to advantages offered by it such as  and compactness.

Request For Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1729

Market Dynamics

Increasing demand for compact and smart devices for estimating pressure are the major factors boosting  of the global pressure monitoring device market. There is been  in  of people facing hypertension and related disease. For instance, in 2008,  Health Organization (WHO) reported 9.4 million deaths worldwide every year due to hypertension, which in turn increased the demand for tools and services to manage their symptoms. The technological advancements in pressure monitoring devices are driving  of the pressure monitoring devices market. For instance, Blumio, the U.S. based medical device developer designed a wearable blood sensor that can continuously monitor blood pressure without requiring an inflatable cuff, enabling users to track and monitor blood pressure throughout the day. Furthermore, increasing awareness among the patients regarding disease monitoring and fitness is expected to boost  of  pressure monitoring device market over the forecast period. However, inaccuracy of the devices in monitoring medical parameters by fluctuating the actual and displayed results is expected to restrain market growth. For instance, a survey article published by Oakland University in 2016, reported  out of 126 aneroid blood pressure monitoring devices around 22.6% had calibration error for the clinical applications.

Regional Insights

On the basis of region, the global pressure monitoring device market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America holds the dominant position in  in terms of revenue, owing to quick adoption of technologically advanced devices in this region and  of major market players in this region especially in the U.S. , Asia Pacific region is projected to witness significant growth in the market over the forecast period, owing to a massive pool of vulnerable population to various chronic diseases and wide availability of innovative products offering better solutions to the patient at the marginally lower costs. For Instance, CotinUse Biometrics Ltd. an Israel based company uses laser nanotechnology to measure blood pressure, respiration, lung activity, and muscle activity simultaneously.

Competitive Insights

The key players operating in the global pressure monitoring devices market include Smiths Groups Plc., Omron, Welch Allyn, Microlife Corporation, General Electric Company, Koninklijke Philips N.N., Halma plc, Hill-Rom Holdings, Inc., A&D Company, Spacelabs Healthcare, Criticare Technologies, , CITIZEN  JAPAN, ERKA, Opto Circuits, Beurer, CAS Medical , Geratherm Haiying Medical, Medical, Nihon Kohden, Schiller, Shenzhen Mindray Bio-Medical Electronics, Vasomedical, Gaeltec Devices, Rudolf Riester, Rossmax International, Truly Healthcare, and Norditalia. Key players are engaged in developing new technologies in order to retain  position in the market. For instance, Microlife Corporation introduced AIFB technology inside its BP monitors, which allows patients to screen for Atrial Fibrillation (AF) during the blood pressure measurement process.


About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Immunoglobulin Market Size Will Escalate Rapidly in the Near Future


Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody immune response is highly complex and very specific. The various immunoglobulin classes and subclasses (isotypes) differ in their biological features, structure, target specificity and distribution. Hence, the assessment of the immunoglobulin isotype can provide useful insight into complex humoral immune response. There are different classes of immunoglobulin such as IgG, IgA, and IgM, which are used for the treatment of various immunological and neurological diseases. These immunoglobulins can be administered intravenously and subcutaneously.

Download PDF Brochure of This Business Report at https://www.coherentmarketinsights.com/insight/request-pdf/1712

Immunoglobulin Market Dynamics

Furthermore, increasing application of immunoglobulin is gaining significant traction among pharmaceutical and Biopharmaceuticals Company for the research and development of immunoglobulin. Moreover, increasing number of intravenous product approvals and clinical trials for new clinical applications is anticipated to provide potential growth opportunities to the industry. For instance, in May 2018, ADMA Biologics, Inc. announced that the company had received U.S. patent for treating respiratory infection. The patent consist of usage of polyclonal immunoglobulin preparation for treatment of respiratory infection, where the issued patent extends to January 2035.

Kedrioin Biopharma and Kamada Ltd. together in May 2018, launched two human-derived protein therapeutics companies announced that KEDRAB [Rabies Immune Globulin (Human)] has been launched in the U.S. as it has received U.S. Food and Drug Administration approval for passive, transient post-exposure prophylaxis of rabies infection, when given immediately after contact with a rabid or possibly rabid animal and concurrent with the rabies vaccine. Such advancement and launches in field of immunoglobulin are expected to foster growth of the immunoglobulin market in near future.

Immunoglobulin Market - Regional Insights

Geographically, global Immunoglobulin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America accounted for the largest share in the immunoglobulin market, followed by Europe in 2016. This is attributed to increasing number of the U.S. Food and Drug Administration approval for immunoglobulin. For instance, in 2016, Shire plc. announced the launch of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] the first and only Subcutaneous 20% treatment option without proline available in the U.S. to treat adult and pediatric patients (two years of age and older) with primary immunodeficiency (PI).

Immunoglobulin Market - Competitive Analysis

The major players operating in the market include Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare. Other players in the immunoglobulin market include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products Co., Ltd., Option Care Enterprises, Inc., ADMA Biologics, Inc., and BioScrip, Inc.

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com
https://www.coherentmarketinsights.com/phase-xs/

Grab Best Discount on This Business Report at https://www.coherentmarketinsights.com/insight/request-discount/1712

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Wednesday, 20 February 2019

Central Venous Catheter Market Present Scenario and the Growth Prospects 2018 – 2026


Central venous catheters consist of a long, thin tube that is inserted into a large vein to deliver medication, nutrition, intravenous fluids, and cancer medications. Different types of central venous catheters can be utilized by patients according to the duration of the treatment, which includes tunneled central venous catheters (CVC) and implanted ports for long term use, peripherally inserted central catheter (PICC) for intermediate term and nontunneled CVC for short term use.

Market Dynamics

Increasing prevalence of renal diseases is a major factor driving central venous catheter market growth. According to the research survey done by U.S. Renal Data System (USRDS), in 2017, around 440,000 patients are living with End-Stage Renal Disease (ESRD) in the U.S and require hemodialysis for survival annually. Moreover, introduction of innovative products and increasing requirement of long-duration IV therapies such as chemotherapy is expected to boost the market growth. For instance, in May, 2018, Pursuit Vascular, Inc., received U.S. Food and Drug Administration (FDA) clearance for a broader indication of its ClearGuard HD caps to include reduction in the incidence of central-line associated bloodstream infection (CLABSI) in hemodialysis patients with central venous catheters (CVCs).


Increasing prevalence of cancer and renal diseases is expected to propel growth of central venous catheter market

Central venous catheterization is used for chemotherapy administration, total parenteral nutrition, administration of intravenous fluids, administration of blood and platelet transfusions, and other uses. High prevalence of cancer is expected to propel demand for central venous catheterization, which in turn is expected to drive the market growth. According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012 and in 2015, cancer was responsible for 8.8 million deaths worldwide. Moreover, WHO stated that the number of new cases is expected to rise by around 70% by 2030.

Similarly, according to the study by University of California, 2014, around 2 million people worldwide are affected by end stage renal disease (ESRD) and the number of patients diagnosed with the disease is expected to increase at a rate of 5-7% annually.

Increasing adoption of central venous catheters in North America is expected to bolster the market growth

North America holds dominant position in the global central venous catheter market, owing to high availability of catheters in medical settings. According to the survey by PavMed, 2016, around 7 million central vascular access devices are utilized annually in the U.S., which includes 400-500,000 implantable ports. Increasing prevalence of cancer in the region is also expected to boost the market growth. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

Key Players

Major players operating in the global central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.


Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702